Skip to content

Click chemistry-assisted synthesis of benzimidazole-1,2,3-triazole hybrids as potential anticancer and antioxidant agents: Integrated in vitro, in silico docking, ADMET, molecular dynamics, and DFT studies

Oct 2026 · Synthetic Communications · Vol 56, pp. 1566 - 1609 · 0 citations · 94 references

Abstract

Abstract This study details the rational design and synthesis of benzimidazole–1,2,3-triazole hybrids (10a-10o) as potential CDK2 inhibitors for anticancer treatment. Molecular docking showed strong binding within the ATP-binding site, with key hydrogen bonds to Leu83 and Asp86, as well as hydrophobic and π–π interactions. Docking scores ranged from −7.93 to −3.09 kcal/mol, and MM/GBSA binding energies reached up to −50.01 kcal/mol. Molecular dynamics simulations over 100 ns verified the stability of the protein–ligand complexes. In vitro tests against MCF-7 cells revealed that compound 10e (IC50 = 14.55 µM) was more effective than doxorubicin (IC50 = 15.77 µM), while 10c (IC50 = 20.47 µM) also showed significant activity. Antioxidant assays indicated that compound 10c (IC50 = 50.80 µg/mL) had radical scavenging activity comparable to ascorbic acid (IC50 = 45.20 µg/mL). DFT analysis found that 10e has the lowest HOMO–LUMO gap, implying higher reactivity. PCA and ADMET assessments further supported its potential as a promising drug candidate. Graphical AbstractSynthesis of benzimidazole-1,2,3-triazole hybrid using molecular hybridization and click chemistry, evaluated in silico and in vitro.The figure illustrates a chemical synthesis and evaluation workflow. The left side depicts the synthesis of a hybrid molecule. It begins at the top left with a benzimidazole derivative (with chlorine and a furan ring) reacting in a flask on a hot plate. This process involves "1,2,3-triazole," "Benzimidazole," "Molecular hybridization," and "Click Chemistry" steps. A second reactant, an azide derivative (N3) with an amide and an Ar/Het group, is shown at the bottom left. Green arrows connect these inputs and conceptual steps, leading to a central "Active scaffold." This active scaffold is a complex molecule comprising a benzimidazole-furan core linked to a 1,2,3-triazole ring, which further connects to an amide with an Ar/Het group. From this active scaffold, two black diverging arrows point to evaluation sections on the right. The "In silico" section displays four molecular docking images. These images show compounds (labeled "10i" and "Dox." in some views) interacting with protein ribbon structures, representing computational analysis. The "In vitro" section shows an anatomical illustration of a human breast, with a magnified cross-section detailing normal tissue and a "Cancerous tumor," signifying experimental biological evaluation.

View source

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.